SKU: NM-2201 Category:

NM-2201 (also known as CBL-2201) is an indole-based synthetic cannabinoid that presumably has similar properties to the closely related 5F-PB-22 and NNE1, which are both full agonists and unselectively bind to CB1 and CB2 receptors with low nanomolar affinity.


NM-2201 acts as a full agonist with a binding affinity of 0.332 nM at CB1 and 0.732 nM at CB2 cannabinoid receptors. It has been linked to serious adverse events in users.

Legal status

NM-2201 is specifically banned in Sweden, Germany (Anlage II),[8] and Japan[9] but is also controlled in many other jurisdictions under analogue laws. On May 30, 2018 the United States Drug Enforcement Administration, Department of Justice published a notice of intent to place NM-2201 and 4 other synthetic cannabinoids in schedule I of the Controlled Substances Act. This notice went into effect on June 29, 2018

IUPAC name

Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate

CAS Number




Molar mass

375.443 g·mol−1


There are no reviews yet.

Be the first to review “NM-2201”

Your email address will not be published. Required fields are marked *